These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 26165848)

  • 41. Topical drug delivery systems: a patent review.
    Singh Malik D; Mital N; Kaur G
    Expert Opin Ther Pat; 2016; 26(2):213-28. PubMed ID: 26651499
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Trends in the production methods of orodispersible films.
    Musazzi UM; Khalid GM; Selmin F; Minghetti P; Cilurzo F
    Int J Pharm; 2020 Feb; 576():118963. PubMed ID: 31857185
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Challenges in pediatric drug development: a pharmaceutical industry perspective.
    Rose K
    Paediatr Drugs; 2009; 11(1):57-9. PubMed ID: 19127957
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Physical methods to promote drug delivery on mucosal tissues of the oral cavity.
    Giannola LI; Sutera FM; De Caro V
    Expert Opin Drug Deliv; 2013 Oct; 10(10):1449-62. PubMed ID: 23802558
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A report from the pediatric formulations task force: perspectives on the state of child-friendly oral dosage forms.
    Zajicek A; Fossler MJ; Barrett JS; Worthington JH; Ternik R; Charkoftaki G; Lum S; Breitkreutz J; Baltezor M; Macheras P; Khan M; Agharkar S; MacLaren DD
    AAPS J; 2013 Oct; 15(4):1072-81. PubMed ID: 23907486
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rapidly disintegrating oramucosal drug delivery technologies.
    Reddy D; Pillay V; Choonara YE; du Toit LC
    Pharm Dev Technol; 2009; 14(6):588-601. PubMed ID: 19883248
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pediatric drug development: formulation considerations.
    Ali AA; Charoo NA; Abdallah DB
    Drug Dev Ind Pharm; 2014 Oct; 40(10):1283-99. PubMed ID: 24483293
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Children's medicines in Tanzania: a national survey of administration practices and preferences.
    Adams LV; Craig SR; Mmbaga EJ; Naburi H; Lahey T; Nutt CT; Kisenge R; Noel GJ; Spielberg SP
    PLoS One; 2013; 8(3):e58303. PubMed ID: 23484012
    [TBL] [Abstract][Full Text] [Related]  

  • 49. European Paediatric Formulation Initiative workshop report: Improving the administration of oral liquid medicines in paediatrics using dosing syringes and enteral accessories.
    Walsh J; van Riet-Nales D; Hermans E; de Vries R; Hilton G; Blowers P; Salunke S
    Eur J Pharm Biopharm; 2020 Jun; 151():91-97. PubMed ID: 32289491
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Barriers to administering non-oral formulations in a paediatric population: A semi-structured interview study.
    Venables R; Batchelor H; Stirling H; Marriott J
    Int J Pharm; 2016 Jan; 497(1-2):12-7. PubMed ID: 26611666
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Paediatric Drug Development and Formulation Design-a European Perspective.
    Van Riet-Nales DA; Kozarewicz P; Aylward B; de Vries R; Egberts TC; Rademaker CM; Schobben AF
    AAPS PharmSciTech; 2017 Feb; 18(2):241-249. PubMed ID: 27270905
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Patient centric drug product design in modern drug delivery as an opportunity to increase safety and effectiveness.
    Stegemann S
    Expert Opin Drug Deliv; 2018 Jun; 15(6):619-627. PubMed ID: 29719161
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Application of in vitro biopharmaceutical methods in development of immediate release oral dosage forms intended for paediatric patients.
    Batchelor HK; Kendall R; Desset-Brethes S; Alex R; Ernest TB;
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):833-42. PubMed ID: 23665448
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Formulation and Delivery of Macromolecules.
    Morales JO
    AAPS PharmSciTech; 2017 Jan; 18(1):1-2. PubMed ID: 27943123
    [No Abstract]   [Full Text] [Related]  

  • 55. Advancement in stimuli triggered in situ gelling delivery for local and systemic route.
    Ajazuddin ; Alexander A; Khan J; Giri TK; Tripathi DK; Saraf S; Saraf S
    Expert Opin Drug Deliv; 2012 Dec; 9(12):1573-92. PubMed ID: 23075325
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nano-formulations of drugs: Recent developments, impact and challenges.
    Jeevanandam J; Chan YS; Danquah MK
    Biochimie; 2016; 128-129():99-112. PubMed ID: 27436182
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Raman spectroscopy in pharmaceutical product design.
    Paudel A; Raijada D; Rantanen J
    Adv Drug Deliv Rev; 2015 Jul; 89():3-20. PubMed ID: 25868453
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bridging studies in support of oral pediatric formulation development.
    Ricci BM
    Int J Pharm; 2013 Nov; 457(1):323-6. PubMed ID: 23942015
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Primary packaging considerations in developing medicines for children: oral liquid and powder for constitution.
    Campbell GA; Vallejo E
    J Pharm Sci; 2015 Jan; 104(1):52-62. PubMed ID: 25393927
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recent advances in oral delivery of peptide hormones.
    Varamini P; Toth I
    Expert Opin Drug Deliv; 2016; 13(4):507-22. PubMed ID: 26787260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.